The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC director | DDisposition to issuer Non-Voting Common Stockderivativeindirect: By Fairmount Healthcare Fund II LP | -6,743,321 | - | - | 0 | 42 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Tomas Kiselak | -47,758 | - | - | 0 | 42 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Tomas Kiselak | -10,370 | - | - | 0 | 42 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Tomas Kiselak | -14,461 | - | - | 0 | 42 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Tomas Kiselak | -7,657 | - | - | 0 | 42 d ago |
| Aug 31, 2026 | CIB Grupo Cibest S.A. | Silvina Vatnick director | DDisposition to issuer Units in Grupo Cibest Equity Securities Fundderivativeindirect: Director Voluntary Pension Fund Units | -1,060 | $9.69 | $10k | 20,525 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Greg Smitherman Chief Financial Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -26,667 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Greg Smitherman Chief Financial Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -7,889 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Greg Smitherman Chief Financial Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -4,889 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Greg Smitherman Chief Financial Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -84 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Gregory Rayzman Chief Technology Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -23,056 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Gregory Rayzman Chief Technology Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -13,612 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Gregory Rayzman Chief Technology Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -1,945 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Gregory Rayzman Chief Technology Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -84 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Ruba Qashu director | DDisposition to issuer Stock Options (Right to Buy)derivative | -1,389 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Ruba Qashu director | DDisposition to issuer Stock Options (Right to Buy)derivative | -5,556 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Ruba Qashu director | DDisposition to issuer Stock Options (Right to Buy)derivative | -3,334 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | James Patrick McCormick Chief Executive Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -834 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | James Patrick McCormick Chief Executive Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -5,556 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | James Patrick McCormick Chief Executive Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -44,734 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | James Patrick McCormick Chief Executive Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -11,187 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | James Patrick McCormick Chief Executive Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -84 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Jeffrey E Kirby director | DDisposition to issuer Stock Options (Right to Buy)derivative | -6,667 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Jeffrey E Kirby director | DDisposition to issuer Stock Options (Right to Buy)derivative | -3,334 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Craig K Johnson director | DDisposition to issuer Stock Options (Right to Buy)derivative | -834 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Craig K Johnson director | DDisposition to issuer Stock Options (Right to Buy)derivative | -6,667 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Craig K Johnson director | DDisposition to issuer Stock Options (Right to Buy)derivative | -3,334 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Sheldon Richard Bentley owner | DDisposition to issuer Stock Options (Right to Buy)derivative | -52,778 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Sheldon Richard Bentley owner | DDisposition to issuer Stock Options (Right to Buy)derivative | -3,612 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Sheldon Richard Bentley owner | DDisposition to issuer Stock Options (Right to Buy)derivative | -51,945 | - | - | 0 | 43 d ago |
| Aug 27, 2026 | CSAI CLOUDASTRUCTURE, INC. | Sheldon Richard Bentley owner | DDisposition to issuer Stock Options (Right to Buy)derivative | -84 | - | - | 0 | 43 d ago |
| Sep 1, 2026 | WHD Cactus, Inc. | Joel Bender President | DDisposition to issuer Class B Common Stockindirect: See Footnote10b5-1 | -100,000 | - | - | 9,161,249 | 43 d ago |
| Sep 1, 2026 | WHD Cactus, Inc. | Scott Bender Chairman and CEO | DDisposition to issuer Class B Common Stockindirect: See Footnote10b5-1 | -100,000 | - | - | 9,161,249 | 43 d ago |
| Sep 2, 2026 | HTHT H World Group Ltd | John Jiong Wu director | DDisposition to issuer Ordinary Shares | -9,784,090 | $4.64 | $45M | 65,620 | 43 d ago |
| Aug 31, 2026 | - Invesco Real Estate Income Trust Inc. | Invesco Advisers, Inc. director | DDisposition to issuer Class E Common Stock, $0.01 par value | -8,969 | $28.45 | $255k | 166,899 | 43 d ago |
| Aug 31, 2026 | - Invesco Commercial Real Estate Finance Trust, Inc. | Invesco Advisers, Inc. director | DDisposition to issuer Class E Common Stock, $0.01 par value | -52,637 | $26.04 | $1.4M | 515,246 | 43 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Common Stock | -116,146 | $85.00 | $9.9M | 5,925 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Common Stock | -5,925 | $85.00 | $504k | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $61.76 | $772k | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $61.77 | $772k | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $64.77 | $1.1M | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $66.71 | $1.2M | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $64.68 | $1.1M | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $40.29 | $504k | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,350 | $52.67 | $545k | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Wendell Wierenga director | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,730 | $49.13 | $478k | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Coelho Rogerio Vivaldi director | DDisposition to issuer Common Stock | -13,300 | $85.00 | $1.1M | 5,925 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Coelho Rogerio Vivaldi director | DDisposition to issuer Common Stock | -5,925 | $85.00 | $504k | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Coelho Rogerio Vivaldi director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $56.69 | $2.0M | 0 | 44 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Coelho Rogerio Vivaldi director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,750 | $66.71 | $584k | 0 | 44 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.